To detect and confirm the inhibitors of Smad-FoxH1 binding, we use Luminescence ELISA -based secondary assay by introducing full length FoxH1 peptide from HEK 293 cell lysate (tagged with HA) binding to Smad Protein.  Smad3 inhibitors, by interacting specifically with a single molecular target, cause the disruption of specific Smad-binding interaction which will interfere with TGF-beta response and thereby inhibiting tumor cell growth.    Reagent: 1. Wash Buffer: Tris-buffer Saline (25 mM Tris, 150mM NaCl; pH 7.2), 0.1% BSA, 0.05% Tween-20. 2. Pierce# 15509 (white 96-well) or #15512 (white 384-well) Racti-Bind NeutrAvidin High Binding Capacity Coated Plates. 3. Rockland-# 600-406-382 Biotin Conjugated Affinity purified anti-6X His epitope tag 100ug. 4. Roche# 120138190001. Anti HA Peroxidase, high affinity 3F10. 5. Detection Reagent- Pierce #37070, SuperSignal @ ELISA Pico Chemiluminescent Substrate. 6. Smad3P-Trimer/Monomer purified 1.3ug/ul. Molecular Weight 48.1 kilodaltons (Stored at -80 deg C). 7. HA-Lysate- HEK-293 cells (ATCC) grown in 100x20mm culture dishes and transfected at 50% confluence. Harvested after 24 hours(at approx. 90% confluent) in 1 ml of lysis buffer; Lysate is flash frozen in liquid nitrogen and stored at -80oC Procedures: 1. Wash each well in Reacti-Bind NeutrAvidin plate three times with 300ul of wash buffer. 2. Add 50ul of the biotinylated Anti-His antibody 0.2ug Rockland antibody/well) to each well in Reacti-Bind NeutrAvidin plate. Seal and incubate plate overnight at 4 deg C. 3. Dilute HEK-293 cell lysate in wash buffer 1:50) +/- his-tagged Smad protein (100nM), +/- candidate inhibitor or small molecular. 4. Wash each well in Reacti-Bind NeutrAvidin plate three times with 200ul of wash buffer. 5. Add 49ul of lysate +/- Smad from step #3 and 1ul of compounds in DMSO to each well in Reacti-Bind NeutrAvidin plate. Incubate the plate for 5 hours at 4 deg C. 6. Wash each well in Reacti-Bind NeutrAvidin plate three times with 200ul of wash buffer. 7. Add 50ul of the HRP-conjugated anti-HA (Dilute 1:1000 in wash buffer) to each well and incubate plate for 1 hour at room temperature. 8. Wash each well in Reacti-Bind NeutrAvidin plate three times with 200ul of wash buffer. 9. Add 50 ul of Pierce SuperSignal Pico Chemiluminescent substrate to each well. Read counts on luminometer. 10. The percent of control (%):  [Reading-BL (without Smad)/Reading with Smad]*100% For each compound, a 4 parameter sigmoidal dose-response curve was fitted using software from the R Project for Statistical Computing.  Compounds with IC50 values of greater than 30 uM, or Activity At IC50 values > 60, were considered inactive, compounds with an IC50 equal or less than 30 uM with Activity at IC50 values <= 60 are considered active. The activity score was calculated based on the observed range of the IC50 values obtained, according to the following formula: Compounds with IC50 < 5 were assigned 100 Compounds with IC50 < 15 were assigned 50 Compounds with IC50 < 30 were assigned 25 Inactive compounds are assigned an activity score of 0.
bao:BAO_0000541 "630" ; # "is counter assay of" -> "630"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0000154 bao:BAO_0000543 ; # "has orthogonal assay design" -> "orthogonal assay design"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000357 ; # "has assay format" -> "single protein format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BAO_0000399 bao:BAO_0000282 ; # "has transcription factor" -> "transcription factor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_00020101 ; # "is bioassay type of" -> "protein-protein interaction assay"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "SMAD3/FoxH1-HA" ; # "protein-protein" -> "SMAD3/FoxH1-HA"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
bao:BAO_0000212 bao:BAO_0000129 ; # "has assay method" -> "immunoassay"
bao:BAO_0000212 bao:BAO_0000134 ; # "has assay method" -> "ELISA"
bao:BAO_0000207 bao:BAO_0000051 ; # "has detection method" -> "chemiluminescence"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Identification of small molecular inhibitors that disrupt Smad protein-protein interactions" ; # "screening campaign name" -> "Identification of small molecular inhibitors that disrupt Smad protein-protein interactions"
bao:BAO_0002853 "SMAD Transcription Factor Inhibitors Secondary Dose Response Confirmation" ; # "has assay title" -> "SMAD Transcription Factor Inhibitors Secondary Dose Response Confirmation"
bao:BAO_0003105 <http://purl.obolibrary.org/obo/GO_0005488> ; # "has function" -> "binding"
bao:BAO_0002867 bao:BAO_0000513 ; # "has assay footprint" -> "96 well plate"
bao:BAO_0002863 bao:BAO_0000535 ; # "has concentration throughput" -> "multiple concentration"
bao:BAO_0000109 "4 degree celsius" ; # "has temperature value" -> "4 degree celsius"
bao:BAO_0002833 "5 hour" ; # "has incubation time value" -> "5 hour"
bao:BA0_0090012 "no SMAD3" ; # "has participant" -> "no SMAD3"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "F.M. Hoffmann" ; # "material entity assay provider" -> "F.M. Hoffmann" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0001038 ; # "has participant" -> "Tween 20" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_27780> ; # "has role" -> "detergent"
bao:BA0_0090012 "Mothers against decapentaplegic homolog 3" ; # "has participant" -> "Mothers against decapentaplegic homolog 3"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "4088" ; # "gene ID" -> "4088"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P84022" ; # "uniprot ID" -> "P84022"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "4088" ; # "construct gene ID" -> "4088"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BAO_0002622 bao:BAO_00020127 ; # "has purity value" -> "purified"
bao:BAO_0000502 "\"Anti-HA Peroxidase, Roche, 120138190001\"" ; # "antibody" -> ""Anti-HA Peroxidase, Roche, 120138190001""
bao:BA0_0090012 "Luminol" ; # "has participant" -> "Luminol"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
bao:BAO_0002787 "13" ; # "has concentration-point number" -> "13"
bao:BAO_0002845 "4" ; # "has repetition point-number" -> "4"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie-2" ; # "Annotated by" -> "kunie-2"
